Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Cash from Discontinued Operations (2018)

Historic Cash from Discontinued Operations for Fortress Biotech (FBIO) over the last 1 years, with Q4 2018 value amounting to $5.7 million.

  • Fortress Biotech's Cash from Discontinued Operations changed N/A to $5.7 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$1.8 million, marking a year-over-year change of. This contributed to the annual value of -$1.8 million for FY2018, which is 5695.68% up from last year.
  • As of Q4 2018, Fortress Biotech's Cash from Discontinued Operations stood at $5.7 million.
  • Over the past 5 years, Fortress Biotech's Cash from Discontinued Operations peaked at $5.7 million during Q4 2018, and registered a low of -$7.4 million during Q2 2018.